Caredx announces district court reverses jury decision in patent infringement case overturning prior $96 million verdict

Brisbane, calif.--(business wire)--caredx, inc. (nasdaq: cdna) – the transplant company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that the district court overturned the jury verdict in patent litigation brought by a competitor. the district court ruled that the patents asserted against caredx are invalid. the court reached this determination because the pate.
CDNA Ratings Summary
CDNA Quant Ranking